Similar articles

• Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.

  Alekseev O, Donovan K, Azizkhan-Clifford J. Alekseev O, et al. Invest Ophthalmol Vis Sci. 2014 Feb 3;55(2):706-15. doi: 10.1167/iovs.13-13461. Invest Ophthalmol Vis Sci. 2014. PMID: 24370835 Free PMC article.
• Activation of checkpoint kinase 2 is critical for herpes simplex virus type 1 replication in corneal epithelium.

  Alekseev O, Limonnik V, Donovan K, Azizkhan-Clifford J. Alekseev O, et al. Ophthalmic Res. 2015;53(2):55-64. doi: 10.1159/000366228. Epub 2014 Dec 19. Ophthalmic Res. 2015. PMID: 25531207 Free PMC article.
• Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.

  Kovacs SK, Tiwari V, Prandovszky E, Dosa S, Bacsa S, Valyi-Nagy K, Shukla D, Valyi-Nagy T. Kovacs SK, et al. Curr Eye Res. 2009 Oct;34(10):896-904. doi: 10.3109/02713680903184250. Curr Eye Res. 2009. PMID: 19895317
• Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.

  Noisakran SJ, Carr DJ. Noisakran SJ, et al. Curr Eye Res. 2000 May;20(5):405-12. Curr Eye Res. 2000. PMID: 10855035
• Ocular HSV-1 latency, reactivation and recurrent disease.

  Toma HS, Murina AT, Areaux RG Jr, Neumann DM, Bhattacharjee PS, Foster TP, Kaufman HE, Hill JM. Toma HS, et al. Semin Ophthalmol. 2008 Jul-Aug;23(4):249-73. doi: 10.1080/08820530802111085. Semin Ophthalmol. 2008. PMID: 18584563 Review.